ACA vs EXPO
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 24, 2026
ACA
EXPO
Investment Advisor Scores
EXPO
AI Analyst Insights
Detailed Metrics Comparison
| Metric | ACA | EXPO | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 35.7143 | 29.3255 | EXPO |
| PEG Ratio | 2.2361 | 2.0325 | EXPO |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 1.7% | 12.0% | EXPO |
| Earnings Growth | 448.6% | 15.7% | ACA |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 54.5/100 | 43.6/100 | ACA |
| Profit Margin | 16.8% | 19.7% | EXPO |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
ACA
MarkupPrice above SMA50, rising 50-day trend (6.3% over 20 days), RSI 60
EXPO
MarkupPrice above SMA50, rising 50-day trend (6.8% over 20 days), RSI 67
Fundamentals Snapshot
| Metric | ACA | EXPO |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 28.4 | 24.9 |
| Trailing P/E | 32.3 | 31.5 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.0% | 0.1% |
| Gross Margin | 0.2% | 0.4% |
| Operating Margin | 0.1% | 0.2% |
| EPS | 4.48 | 2.23 |
| Dividend Yield | 0.00% | 0.02% |